Answers are grounded in this paper and cite their sources.
To date, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused more than 223 million confirmed cases of coronavirus disease 2019 (COVID-19), including 4.6 million deaths ( https://covid19.who.int/ ). Since 2020, several SARS-CoV-2 variants including Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), and Delta (B.1.617.2) with immune evasiveness have emerged and fast spread. In a global research effort, scientists proposed multiple effective vaccine strategies to respond to the ongoing COVID-19 pandemic. Most vaccines currently in use or in clinical development target the SARS-CoV-2 Spike (S) glycoprotein, a homotrimer decorates on the viral surface; within it, a distinct receptor-binding domain (RBD, residues 331–524) is responsible for mediating cell entry and interaction with host receptor angiotensin-converting enzyme 2 (ACE2).
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: